Llwytho...

小细胞肺癌驱动基因研究进展

Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains dismal. Screening for the targetable driver mutations of this malignant tumor contributes to improve the therapeutic approaches and outcome. This review will report the advances on some latest driver mutations.

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Zhongguo Fei Ai Za Zhi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 中国肺癌杂志编辑部 2016
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5999810/
https://ncbi.nlm.nih.gov/pubmed/27118653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2016.04.10
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!